Belite Bio, Inc
BLTE
$183.16
-$9.69-5.03%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 13.45M | 12.71M | 6.55M | 6.12M | 4.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.08M | 23.02M | 17.60M | 15.52M | 11.46M |
| Operating Income | -28.08M | -23.02M | -17.60M | -15.52M | -11.46M |
| Income Before Tax | -25.32M | -21.69M | -16.32M | -14.28M | -10.10M |
| Income Tax Expenses | -- | -- | -- | -- | 0.00 |
| Earnings from Continuing Operations | -25.32M | -21.69M | -16.32M | -14.28M | -10.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.32M | -21.69M | -16.32M | -14.28M | -10.10M |
| EBIT | -28.08M | -23.02M | -17.60M | -15.52M | -11.46M |
| EBITDA | -28.03M | -22.97M | -17.55M | -15.48M | -11.41M |
| EPS Basic | -0.70 | -0.65 | -0.50 | -0.45 | -0.32 |
| Normalized Basic EPS | -0.44 | -0.41 | -- | -- | -0.20 |
| EPS Diluted | -0.70 | -0.65 | -0.50 | -0.45 | -0.32 |
| Normalized Diluted EPS | -0.44 | -0.41 | -- | -- | -0.20 |
| Average Basic Shares Outstanding | 36.22M | 33.22M | 32.59M | 32.08M | 31.46M |
| Average Diluted Shares Outstanding | 36.22M | 33.22M | 32.59M | 32.08M | 31.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |